In this episode of Practicing with Medicine Podcast, Dr. Goodyear interviews Neo7Bioscience CEO, Dr. John Catanzaro, NMD on the topic of peptides.
Below we have included the full video interview along with a written summary.
An Interview with Neo7Bioscience CEO – Written Summary
Dr. Constanzaro and Dr. Goodyear are discussing the potential of personalized peptide therapies to treat disease.
They explain that traditional blood tests and imaging cannot detect the hidden faulty signals that are the root cause of disease.
Personalized peptide therapies, on the other hand, can identify these faulty signals and target them with specific peptides.
This approach has the potential to revolutionize the way we treat disease, moving from a model of disease management to one of disease healing.
Dr. Constanzaro also discusses the importance of resilience and regeneration in the context of aging. He argues that personalized peptide therapies can help to slow down the accelerated aging process and extend healthy life.
The following are some key points from the text:
- Personalized peptide therapies can identify and target the hidden faulty signals that are the root cause of the disease.
- This approach has the potential to revolutionize the way we treat disease, moving from a model of disease management to one of disease healing.
- Personalized peptide therapies can also help to slow down the accelerated aging process and extend healthy life.
If you want to learn more about peptides in cancer treatment, I encourage you to listen to the full podcast episode.
Learn More About Dr. John Catanzaro
Dr. John Catanzaro serves as CEO, Founder, Chairman, and Product Development Officer of Neo7Bioscience, a precision/personalized molecular design biotech company.
Dr. Catanzaro received his Doctorate of Naturopathic Medicine (N.M.D.) from Bastyr University in 1995, and his Doctorate of Theology and Ethics (D.T.S; Th.D.) from Bethany Divinity Seminary in 2012.
After 22 years of clinical practice treating patients with cancer and chronic illness, he retired in 2017, where he was the founder and CEO of a cancer institute and research development group of genetic and proteomic technology innovating patient-precision genetically matched immunopeptides.
In addition, Dr. Catanzaro is the coinventor of a precision augmentation platform known as PBIMA. The platform includes multiomic / proteomic sequencing and prediction, CRISPR prime editing features, and proteomics in a 3D integration utilizing unified proprietary mapping informatics and computation, superior ranking, and selection architecture.
Dr. Catanzaro is a thought leader in molecular bioscience and biotechnology and brings forth a wealth of knowledge and experience to architect precision-based personalized therapeutics in healthcare. Before his career in medicine and biosciences, he was engaged in the aerospace industry in various capacities, including stints for the USAF and The Boeing Company.
Learn More About Dr. Goodyear
For more interesting videos from Dr. Goodyear on a variety of topics, TikTok videos are updated daily at @briomedical and long-form videos can be found on our YouTube Channel @BrioMedical.
Patients interested in pursuing their cancer healing journey can visit Dr. Goodyear at Brio Medical in Scottsdale, Arizona.
